A limited sampling method for the estimation of serum calcitriol area under the curve in cancer patients

Journal of Clinical Pharmacology

Volumn 43, Issue 8, 2003, Pages 894-900

  Muindi, Josephia R ^a,c   Wilson, John W ^a   Peng, Ying ^a   Capozolli, Mary Jo ^a   Johnson, Candace S ^b   Trump, Donald L ^b  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

^c UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

Antitumor activity; Calcitriol; Cancer; Limited sampling method; Pharmacokinetics

Indexed keywords

CALCITRIOL; CALCITRIOL I 125; CARBOPLATIN; DEXAMETHASONE; PACLITAXEL; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; AREA UNDER THE CURVE; ARTICLE; BLOOD SAMPLING; CALCULATION; CANCER PATIENT; CLINICAL TRIAL; CORRELATION ANALYSIS; CURVE FITTING; DRUG BLOOD LEVEL; HUMAN; LIMITED SAMPLING METHOD; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; PHASE 1 CLINICAL TRIAL; PREDICTION; RADIOIMMUNOASSAY; STATISTICAL MODEL;

AREA UNDER CURVE; CALCITRIOL; CALCIUM CHANNEL AGONISTS; HUMANS; NEOPLASMS; RADIOIMMUNOASSAY;

EID: 0038637254     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1177/0091270003255925     Document Type: Article

References (15)

1. 3 and malignant melanoma: the presence of receptors and inhibition of cell growth in culture. Endocrine 1981;108:1083-1086.
2. 3 inhibitory effect on the growth of two human breast cancer cell lines (MCF-7, BT-20). J Steroid Biochem 1986;24:373-376.
3. Cross HS, Pavelka M, Slavik J, Peterlik M: Growth control of human colon cancer cells by vitamin D and calcium in vitro. J Natl Cancer Inst 1992;84:1355-1357.
4. 3 receptors and actions in human prostate cancer cell lines. Endocrinol 1993;132:1952-1960.
5. 3 on primary cultures of human prostatic cells. Cancer Res 1994;54:805-810.
6. Beer TM, Hough KM, Garzotto M, Lowe BA, Henner WD: Weekly high dose calcitriol and docetaxel in advanced prostate cancer. Semin Oncol 2001;28(Suppl. 15):49-55.
7. Smith DC, Johnson CS, Freeman CC, Muindi J, Wilson JW, Trump DL, et al: A phase I trial of calcitriol (1,25-dihydroxycholecalciferal) in patients with advanced malignancy. Clin Cancer Res 1999;5:1339-1345.
8. Muindi JR, Peng Y, Potter DM, Hershberger PA, Tauch JS, Capozzoli MJ, et al: Pharmacokinetics of high dose, oral calcitriol: results from a phase 1 trial of calcitriol and paclitaxel. Clin Pharmacol Ther 2002;72:648-659.
9. 3 in plasma. Anal Biochem 1992;204:258-264.
10. 3 in human plasma. J Chromatography B 1997;690:15-23.
11. 3-26, 23-lactone interferes in the determination of by RIA after immunoextraction. Clin Chem 1995;41:1313-1314.
12. Tallarida RJ, Murray RB: Manual of Pharmacologic Calculation with Computer Programs. New York: Springer-Verlag, 1986.
13. Snee RD: Validation of regression models: methods and examples. Technometrics 1977;19:415-428.
14. 3-mediated antitumor activity with dexamethasone. J Natl Cancer Inst 1998;90:134-141.
15. Light BW, Yu WD, McElwain MC, Russell DM, Trump DL, Johnson CS: Potentiation of cisplatin antitumor activity using a vitamin D analogue in a murine squamous cell carcinoma model system. Cancer Res 1997;57:3759-3764.